Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism EGFR C797S inhibitors(Epidermal Growth Factor Receptor C797S inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
EGFR positive non-small cell lung cancer | Preclinical | KR | Cyrus Therapeutics, Inc.Startup | 15 Jun 2022 |
EGFR positive non-small cell lung cancer | Preclinical | KR | 15 Jun 2022 |